Anti-IL-6/IFNb2 Antibody (Elsilimomab)
Catalog No.
F1276
Anti-IL-6/IFNb2 Antibody (Elsilimomab)
Featured Products
Elsilimomab (B-E8) is an anti-interleukin-6 (IL-6) IgG1 monoclonal antibody with a KD of 22 pM and an IC50 of 1.4 nM. Elsilimomab can be used in the research of multiple myeloma, renal cell carcinoma, and rheumatoid arthritis (RA).
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145 kDa
Dry ice
468715-71-1
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
BE-8, Elsilimomab
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P05231
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human IL-6 His at 2 ug/mL can bind Anti-IL-6/IFNb2 Antibody (Elsilimomab)
IL-6 / IFNb2
Please avoid freeze-thaw cycles.